Taiwan FDA registration 3308f4f66ec10d35fc2919ab11e916ab

Cutting-edge medical morphine rapid test reagents

TW: 尖端醫嗎啡快速檢驗試劑

Taiwan·Risk Class 2·TAIWAN ADVANCE BIO-PHARMACEUTICAL INC.·Registered Aug 30, 2023 – Aug 30, 2028Active

Registration details

Analysis ID: 3308f4f66ec10d35fc2919ab11e916ab

Company information

Manufacturer: TAIWAN ADVANCE BIO-PHARMACEUTICAL INC.
Manufacturer Country: Taiwan, Province of China
Authorized Representative: TAIWAN ADVANCE BIO-PHARMACEUTICAL INC.

Product details

Intended Use: This product uses competitive immunolayer analysis to qualitatively detect morphine in human urine, and the test results can be used as a preliminary screening test. The morphine threshold is set at 300ng/mL. This product can be used by both general individuals and professionals.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.3640 嗎啡試驗系統
Import Information: 國產;; QMS/QSD

Dates and status

Registration Date: Aug 30, 2023
Expiry Date: Aug 30, 2028

About this record

Access comprehensive regulatory information for Cutting-edge medical morphine rapid test reagents in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3308f4f66ec10d35fc2919ab11e916ab and manufactured by TAIWAN ADVANCE BIO-PHARMACEUTICAL INC.. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.